跳至主要内容
临床试验/IRCT20160307026950N19
IRCT20160307026950N19已完成3 期

Comparison of the effectiveness of low-dose Esmolol and Labetalol on changes in heart rate and blood pressure in patients treated with electroshock (ECT)

Esfahan University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
13 years 至 19 years(—)
性别
All

入选标准

  • Candidate for electroshock therapy
  • Range of 13 to 19 years
  • ASA class I and II
  • The patient's consent to participate in the study

排除标准

  • Contraindications to the use of Esmolol and Labetalol
  • Previous consumption of beta-blockers
  • Sensitivity to Esmolal and labetalol
  • Asthma and drug allergies
  • History of severe cardiovascular disease, chronic respiratory disease, kidney disease, and liver disease

研究者

相似试验